Decoy Therapeutics Inc. (DCOY): Total Assets
$11.06M
As of 2025-12-31
$9.00M
As of 2026-06-30
-9.0%
3-year compound annual growth
-15.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.06M | +265.8% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $3.02M | -54.1% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $6.59M | -55.0% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $14.65M | -64.1% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $40.83M | +63.8% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $24.93M | +79.4% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $13.89M | +110.1% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $6.61M | n/c | 2020-03-23, Balance as of period end |
| 2017-12-31 | $34.99M | -44.6% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $63.21M | -33.5% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $95.07M | +167.0% | 2017-03-08, Balance as of period end |
| 2014-12-31 | $35.61M | n/a | 2016-03-08, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $11.06M | +265.8% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $11.09M | +279.5% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $11.12M | -31.6% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $11.45M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
Compare DCOY, LTRN, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗